AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 26.41 million compared to USD 32.54 million a year ago. Basic loss per share from continuing operations was USD 0.93 compared to USD 1.18 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.36 USD | -2.30% | -2.46% | +9.06% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.06% | 638M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.22% | 21.83B | |
-10.95% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022